Patents by Inventor Guy P. Curtis

Guy P. Curtis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260102138
    Abstract: A device for establishing a fluid communication pathway to a target point in a patient includes a bi-plane ultrasound probe. A transverse plane of the probe identifies a target point in the patient, and a longitudinal plane of the probe is used to monitor 2D ultrasound signals in a segment of an artery extending downstream from the target point. By moving the longitudinal plane to optimize the received 2D ultrasound signals, a pathway to the target point is thus determined for the medical use of arteriotomy needles and/or catheters.
    Type: Application
    Filed: October 11, 2024
    Publication date: April 16, 2026
    Inventors: Guy P. Curtis, Robert Russo
  • Publication number: 20250366729
    Abstract: An electronic device that monitors blood pressure in vasculature of an individual is described. This electronic device may perform the operations of: monitoring blood flow of the individual (e.g., using a pulse oximeter); calibrating the blood flow based at least in part on a predefined or predetermined comparison of the blood flow and blood pressure, e.g., in the individual's vasculature; and providing the calibrated blood flow of the individual as a function of time, where the calibrated blood flow indicates at least the blood pressure or a blood-pressure reading for the individual.
    Type: Application
    Filed: August 11, 2025
    Publication date: December 4, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20250325203
    Abstract: An electronic device that evaluates a cardiac pumping function is described. This electronic device may perform the operations of: monitoring an instance of a pulse oximeter waveform of an individual; computing metric information associated with the instance of the pulse oximeter waveform; and calculating a rate of rise or fall of the instance of the pulse oximeter waveform as a function of time. In some embodiments, the electronic device may provide a recommended remedial action based at least in part on the calculated rate or rise of fall in the instance of the pulse oximeter waveform.
    Type: Application
    Filed: June 27, 2025
    Publication date: October 23, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20250255505
    Abstract: A system and method for monitoring a patient's blood flow waveform require a pulse oximeter to non-invasively measure changes in parametric and blood flow measurements of the waveform. These parametric measurements, namely changes in diastolic pressure, ±?pd, changes in systolic pressure, ±?ps, and changes in pulse time rate, ±?tr, collectively affect the patient's blood flow volume. Thus, they can also be used, collectively, to assess the patient's heart muscle function as an indicator of his/her health condition.
    Type: Application
    Filed: February 10, 2024
    Publication date: August 14, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20250255518
    Abstract: A system and methodology are provided for using a pulse oximeter to monitor a patient's blood flow trends over extended periods of time. For this purpose, changes in oxygen saturation levels which result in infrared color wavelength changes are detected by a pulse oximeter and then compared directly to a base infrared wavelength which was previously correlated with a systolic pressure taken by a sphygmomanometer. Thus, infrared color changes in the patient's blood pressure pulse are used to monitor trends in the patient's blood flow. A correlation factor is established which correlates a predetermined difference between wavelength colors detected by the pulse oximeter with blood pressure measurements taken by a sphygmomanometer. Variations of this correlation factor can then be subsequently monitored independently by the pulse oximeter and compared relative to previously established parameters for blood flow.
    Type: Application
    Filed: November 30, 2024
    Publication date: August 14, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20250255506
    Abstract: A system and methodology are provided for using a pulse oximeter to continuously measure a patient's blood flow over extended periods of time. For this purpose, a correlation factor is established which correlates a predetermined difference between wavelength colors detected by the pulse oximeter with blood pressure measurements taken by a sphygmomanometer. Variations of this correlation factor can then be subsequently monitored independently by the pulse oximeter and compared relative to previously established parameters for blood flow. Clinical personnel are thereby alerted when attention to the patient's health condition is required.
    Type: Application
    Filed: October 11, 2024
    Publication date: August 14, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20250143586
    Abstract: A system for evaluating a cardiac pumping function includes an oximeter which is attached to a patient for the purpose of recording a pulse oximeter waveform. A computer is connected to the oximeter to receive metric information from the waveform. With this information, the computer determines the value and location of a second derivative acceleration, d2A/dt2 in the waveform, which indicates the rate of rise/fall of the waveform. A comparator in the computer then compares this with the value and location of maximum second derivative acceleration, d2A/dt2, in earlier waveforms. With this comparison, the computer identifies a trend which can be clinically used to evaluate the efficacy of a cardiac pumping function.
    Type: Application
    Filed: January 12, 2025
    Publication date: May 8, 2025
    Inventor: Guy P. Curtis
  • Publication number: 20240090788
    Abstract: The present invention pertains to a system and method for evaluating the blood volume-flow waveform of a patient for the purpose of determining ventricular contractibility. Input data for this evaluation includes measurements of oxygen saturation levels (SpO2) in the waveform and a time duration for a respective cardiac cycle. Specifically, the oxygen saturation level SpO2 in a waveform is indicative of an arterial blood-flow volume “V”. The data processor of a computer is then used for calculating a maximum rate of change in the arterial blood-flow volume “V” per time dV/dt. In accordance with the present invention, the maximum dV/dt for a succession of cardiac cycles are then compared for a clinical evaluation of trends in a patient's ventricular contractibility.
    Type: Application
    Filed: January 28, 2023
    Publication date: March 21, 2024
    Inventor: Guy P. Curtis
  • Publication number: 20230329645
    Abstract: A system and method for using an oximeter that monitors a patient's blood pressure over an extended time duration requires creating a line graph. In detail, the line graph is created to provide a steady state correlation between blood flow measurements taken by the oximeter and blood pressure measurements taken by a sphygmomanometer. To create this graph, blood pressure measurements (sphygmomanometer) and blood flow measurements (oximeter) are recorded together and collated during a heart muscle cycle of the patient. Specifically, these measurements are considered together during the same heart muscle cycle while the patient is either standing, sitting, or reclining. This establishes three respective data sets which are then used as reference points to create the line-graph. Thereafter, blood flow measurements with the oximeter can be referenced to the line-graph for direct indications of blood pressure.
    Type: Application
    Filed: June 17, 2023
    Publication date: October 19, 2023
    Inventor: Guy P. Curtis
  • Publication number: 20230225621
    Abstract: A system for evaluating a cardiac pumping function includes an oximeter which is attached to a patient for the purpose of recording a pulse oximeter waveform. A computer is connected to the oximeter to receive metric information from the waveform. With this information, the computer determines the value and location of a second derivative acceleration, d2A/dt2 in the waveform, which indicates the rate of rise/fall of the waveform. A comparator in the computer then compares this with the value and location of maximum second derivative acceleration, d2A/dt2, in earlier waveforms. With this comparison, the computer identifies a trend which can be clinically used to evaluate the efficacy of a cardiac pumping function.
    Type: Application
    Filed: January 20, 2022
    Publication date: July 20, 2023
    Inventor: Guy P. Curtis
  • Patent number: 11565113
    Abstract: A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval ?t at a time t0. Importantly, the stimulation interval ?t is set to end at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: January 31, 2023
    Assignee: GUY P. CURTIS AND FRANCES L. CURTIS TRUST
    Inventor: Guy P. Curtis
  • Publication number: 20220328178
    Abstract: A system for using an oximeter to provide blood pressure readings relies on a comparative interface between readings of a patient's blood flow waveform (oximeter) and blood pressure (sphygmomanometer) in his/her vasculature. For this purpose, a steady state condition is identified by calibrating a blood flow measurement A from the oximeter with a simultaneously obtained blood pressure measurement P from the sphygmomanometer. Further, using these simultaneous measurements, a blood pressure model is created that is based on the steady state. Thereafter, blood flow waveform readings from the oximeter are correlated with the steady state model to provide continuous blood pressure readings.
    Type: Application
    Filed: October 7, 2021
    Publication date: October 13, 2022
    Inventor: Guy P. Curtis
  • Patent number: 11167145
    Abstract: A system for monitoring and evaluating the ventricular contractility of a heart muscle includes a device for electrically stimulating the heart muscle of a patient, and an extracorporeal blood pressure sensor. A record, responsive to stimulated ventricular contractions, is created by the pressure sensor. The response record is then evaluated to identify a pressure/time, rate-change in arterial pressure (dp/dt) that results within the time duration of a ventricular contraction in a cardiac cycle. In turn, dp/dt is evaluated as an indicator of ventricular contractility and the health of the patient's heart muscle.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: November 9, 2021
    Assignee: Guy P. Curtis and Frances L. Curtis Trust
    Inventor: Guy P. Curtis
  • Publication number: 20210322247
    Abstract: A protocol for the treatment of lumbosacral spine disease requires the combination of physical and pharmaceutical therapies. For the physical therapy aspect of the present invention, an inversion table is used to periodically impose traction forces of the spine of a patient. Preferably, this is done with the patient lying supine on the inversion table in a head down orientation, with the inversion table inclined at a predetermined angle in a range that includes 45°, for a predetermined time interval that includes 3 to 4 minutes. A pharmaceutical therapy is also clinically prescribed, in conjunction with the physical therapy aspect, that requires ingesting a nonsteroidal anti-inflammatory drug (NSAID), a muscle relaxant, and an antiarrhythmic drug in accordance with a predetermined regimen.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 21, 2021
    Inventor: Guy P. Curtis
  • Publication number: 20210128924
    Abstract: A system for monitoring and evaluating the ventricular contractility of a heart muscle includes a device for electrically stimulating the heart muscle of a patient, and an extracorporeal blood pressure sensor. A record, responsive to stimulated ventricular contractions, is created by the pressure sensor. The response record is then evaluated to identify a pressure/time, rate-change in arterial pressure (dp/dt) that results within the time duration of a ventricular contraction in a cardiac cycle. In turn, dp/dt is evaluated as an indicator of ventricular contractility and the health of the patient's heart muscle.
    Type: Application
    Filed: October 30, 2019
    Publication date: May 6, 2021
    Inventor: Guy P. Curtis
  • Publication number: 20200398056
    Abstract: A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval ?t at a time t0. Importantly, the stimulation interval ?t is set to end at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.
    Type: Application
    Filed: October 15, 2019
    Publication date: December 24, 2020
    Inventor: Guy P. Curtis
  • Publication number: 20200038661
    Abstract: A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval ?t at a time t0. Importantly, the stimulation interval ?t is set to end at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.
    Type: Application
    Filed: October 15, 2019
    Publication date: February 6, 2020
    Inventor: Guy P. Curtis
  • Patent number: 10232184
    Abstract: A system is provided for testing the electrical integrity of an implanted pacemaker or defibrillator lead. The system includes a container holding an electrically conductive solution, such as a saline solution. A voltage source and two electrodes are provided to pass an electrical current through the solution. To use the system, the proximal end of the electrical lead is disconnected from the implanted electronic device, passed through the saline solution and then electrically connected to a device/monitor. During testing, the device/monitor sends a test pulse through the lead and monitors electrical activity in the lead. To test sequential locations along the length of the proximal segment, the segment is drawn through the saline solution and between the electrodes while test pulses are sent and monitored. The monitor detects abnormal electrical activity in the lead indicative of a break in lead insulation.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: March 19, 2019
    Assignee: THE GUY P. CURTIS AND FRANCES L. CURTIS TRUST
    Inventor: Guy P. Curtis
  • Patent number: 10124152
    Abstract: A system and method for perfusing a liquid medicament into tissue of a patient requires a catheter having a distal barrier and a proximal barrier mounted on the catheter. A perfusion section is formed into the catheter between these barriers. By way of example of a typical operation, the catheter is advanced through the vasculature of a patient and into the coronary sinus. Advancement continues until the barriers of the catheter are positioned to straddle the ostium of the left atrial vein. As so positioned, a perfusion chamber is established in the coronary sinus between the barriers. Also, the perfusion chamber is positioned for fluid communication with the left atrial vein. Liquid medicament can then be transferred from a source into the perfusion chamber for perfusion of the medicament into tissue of the atrial vein.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: November 13, 2018
    Assignee: GUY P. CURTIS AND FRANCES L. CURTIS TRUST
    Inventor: Guy P. Curtis
  • Patent number: 10117982
    Abstract: A system for improving heart muscle response during a pre-ejection phase in the heart muscle pumping cycle requires a catheter having a pressure transducer and a fluid device mounted at its distal end. Also included is a pump connected to the proximal end of the catheter in fluid communication with the fluid device. A computer will activate the pump in response to a predetermined signal from the pressure transducer to inject and maintain an increased fluid volume in the pumping chamber of the heart for a predetermined time interval ?t during the pre-ejection phase. This supplements the isometric pressure in the heart's pumping chamber in preparation for a subsequent ejection of blood from the pumping chamber.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: November 6, 2018
    Assignee: Guy P. Curtis and Frances L. Curtis Trust
    Inventor: Guy P. Curtis